Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries
Gespeichert in:
| Veröffentlicht in: | Intensive care medicine 2015-02, Vol.41 (2), p.371-372 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 372 |
|---|---|
| container_issue | 2 |
| container_start_page | 371 |
| container_title | Intensive care medicine |
| container_volume | 41 |
| creator | Asensio, M. J. Sánchez, M. Galván, B. Herrero, E. Cachafeiro, L. Agrifoglio, A. Perales, E. Luque, S. García-de-Lorenzo, A. |
| description | |
| doi_str_mv | 10.1007/s00134-014-3586-z |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1652460193</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A724290916</galeid><sourcerecordid>A724290916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-4c9d97b1e031fe28a397999f34f396e1b95a95cf50b4d6e4053ddfe7c9175b8d3</originalsourceid><addsrcrecordid>eNp1ks1u1TAQhSMEopfCA7BBltiwSWvHdhIvq4o_qYgNrK2JPU59lTipnQC3e96DZ-HJ8NUtv7poFpbG3zkej05RPGX0jFHanCdKGRclZaLksq3L23vFhglelazi7f1iQ7moSlGL6qR4lNI2000t2cPipJKiloqqTfH1nTfg1tD7QGAhQNICwUK0xE4JeiSTI_mt79_G_tzCjoC59vgJEwGLNyssSOYB0ggEv8xTWiOSbGSiX7LtMOyIHwYyw-IxLIl89ss1SVmesW6NIbPbNXpMj4sHDoaET-7O0-Ljq5cfLt-UV-9fv728uCqNFM1SCqOsajqGlDOHVQtcNUopx4XjqkbWKQlKGidpJ2yNgkpurcPGKNbIrrX8tHhx8J3jdLNiWvTok8FhgIDTmjSrZSVqyhTP6PN_0O2UR87T7SnaCtrUzW-qhwG1D25aIpi9qb5oKlHlHbM6U-URqseAEYYpoPO5_Rd_doTPZXH05qiAHQQmTilFdHqOfoS404zqfVT0ISo6R0Xvo6Jvs-bZ3QfXbkT7S_EzGxmoDkDKV6HH-McG_uv6A-cNyWM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1650840767</pqid></control><display><type>article</type><title>Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Asensio, M. J. ; Sánchez, M. ; Galván, B. ; Herrero, E. ; Cachafeiro, L. ; Agrifoglio, A. ; Perales, E. ; Luque, S. ; García-de-Lorenzo, A.</creator><creatorcontrib>Asensio, M. J. ; Sánchez, M. ; Galván, B. ; Herrero, E. ; Cachafeiro, L. ; Agrifoglio, A. ; Perales, E. ; Luque, S. ; García-de-Lorenzo, A.</creatorcontrib><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s00134-014-3586-z</identifier><identifier>PMID: 25465909</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adolescent ; Adult ; Aged ; Anesthesiology ; Antifungal Agents - administration & dosage ; Antifungal Agents - blood ; Antifungal Agents - therapeutic use ; Burns ; Burns - complications ; Burns - drug therapy ; Burns and scalds ; Candidiasis, Invasive - drug therapy ; Caspofungin ; Critical Care ; Critical Care Medicine ; Critical Illness ; Drug dosages ; Echinocandins - administration & dosage ; Echinocandins - blood ; Echinocandins - therapeutic use ; Emergency Medicine ; Female ; Health aspects ; Humans ; Infections ; Intensive ; Intensive care ; Letter ; Lipopeptides - administration & dosage ; Lipopeptides - blood ; Lipopeptides - therapeutic use ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Mortality ; Pain Medicine ; Patients ; Pediatrics ; Pharmacokinetics ; Plasma ; Plasma physics ; Pneumology/Respiratory System ; Wound Infection - drug therapy ; Young Adult</subject><ispartof>Intensive care medicine, 2015-02, Vol.41 (2), p.371-372</ispartof><rights>Springer-Verlag Berlin Heidelberg and ESICM 2014</rights><rights>COPYRIGHT 2015 Springer</rights><rights>Springer-Verlag Berlin Heidelberg and ESICM 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-4c9d97b1e031fe28a397999f34f396e1b95a95cf50b4d6e4053ddfe7c9175b8d3</citedby><cites>FETCH-LOGICAL-c547t-4c9d97b1e031fe28a397999f34f396e1b95a95cf50b4d6e4053ddfe7c9175b8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00134-014-3586-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00134-014-3586-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25465909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asensio, M. J.</creatorcontrib><creatorcontrib>Sánchez, M.</creatorcontrib><creatorcontrib>Galván, B.</creatorcontrib><creatorcontrib>Herrero, E.</creatorcontrib><creatorcontrib>Cachafeiro, L.</creatorcontrib><creatorcontrib>Agrifoglio, A.</creatorcontrib><creatorcontrib>Perales, E.</creatorcontrib><creatorcontrib>Luque, S.</creatorcontrib><creatorcontrib>García-de-Lorenzo, A.</creatorcontrib><title>Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><addtitle>Intensive Care Med</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anesthesiology</subject><subject>Antifungal Agents - administration & dosage</subject><subject>Antifungal Agents - blood</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Burns</subject><subject>Burns - complications</subject><subject>Burns - drug therapy</subject><subject>Burns and scalds</subject><subject>Candidiasis, Invasive - drug therapy</subject><subject>Caspofungin</subject><subject>Critical Care</subject><subject>Critical Care Medicine</subject><subject>Critical Illness</subject><subject>Drug dosages</subject><subject>Echinocandins - administration & dosage</subject><subject>Echinocandins - blood</subject><subject>Echinocandins - therapeutic use</subject><subject>Emergency Medicine</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Infections</subject><subject>Intensive</subject><subject>Intensive care</subject><subject>Letter</subject><subject>Lipopeptides - administration & dosage</subject><subject>Lipopeptides - blood</subject><subject>Lipopeptides - therapeutic use</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Pain Medicine</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Pharmacokinetics</subject><subject>Plasma</subject><subject>Plasma physics</subject><subject>Pneumology/Respiratory System</subject><subject>Wound Infection - drug therapy</subject><subject>Young Adult</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1ks1u1TAQhSMEopfCA7BBltiwSWvHdhIvq4o_qYgNrK2JPU59lTipnQC3e96DZ-HJ8NUtv7poFpbG3zkej05RPGX0jFHanCdKGRclZaLksq3L23vFhglelazi7f1iQ7moSlGL6qR4lNI2000t2cPipJKiloqqTfH1nTfg1tD7QGAhQNICwUK0xE4JeiSTI_mt79_G_tzCjoC59vgJEwGLNyssSOYB0ggEv8xTWiOSbGSiX7LtMOyIHwYyw-IxLIl89ss1SVmesW6NIbPbNXpMj4sHDoaET-7O0-Ljq5cfLt-UV-9fv728uCqNFM1SCqOsajqGlDOHVQtcNUopx4XjqkbWKQlKGidpJ2yNgkpurcPGKNbIrrX8tHhx8J3jdLNiWvTok8FhgIDTmjSrZSVqyhTP6PN_0O2UR87T7SnaCtrUzW-qhwG1D25aIpi9qb5oKlHlHbM6U-URqseAEYYpoPO5_Rd_doTPZXH05qiAHQQmTilFdHqOfoS404zqfVT0ISo6R0Xvo6Jvs-bZ3QfXbkT7S_EzGxmoDkDKV6HH-McG_uv6A-cNyWM</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Asensio, M. J.</creator><creator>Sánchez, M.</creator><creator>Galván, B.</creator><creator>Herrero, E.</creator><creator>Cachafeiro, L.</creator><creator>Agrifoglio, A.</creator><creator>Perales, E.</creator><creator>Luque, S.</creator><creator>García-de-Lorenzo, A.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150201</creationdate><title>Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries</title><author>Asensio, M. J. ; Sánchez, M. ; Galván, B. ; Herrero, E. ; Cachafeiro, L. ; Agrifoglio, A. ; Perales, E. ; Luque, S. ; García-de-Lorenzo, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-4c9d97b1e031fe28a397999f34f396e1b95a95cf50b4d6e4053ddfe7c9175b8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anesthesiology</topic><topic>Antifungal Agents - administration & dosage</topic><topic>Antifungal Agents - blood</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Burns</topic><topic>Burns - complications</topic><topic>Burns - drug therapy</topic><topic>Burns and scalds</topic><topic>Candidiasis, Invasive - drug therapy</topic><topic>Caspofungin</topic><topic>Critical Care</topic><topic>Critical Care Medicine</topic><topic>Critical Illness</topic><topic>Drug dosages</topic><topic>Echinocandins - administration & dosage</topic><topic>Echinocandins - blood</topic><topic>Echinocandins - therapeutic use</topic><topic>Emergency Medicine</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Infections</topic><topic>Intensive</topic><topic>Intensive care</topic><topic>Letter</topic><topic>Lipopeptides - administration & dosage</topic><topic>Lipopeptides - blood</topic><topic>Lipopeptides - therapeutic use</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Pain Medicine</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Pharmacokinetics</topic><topic>Plasma</topic><topic>Plasma physics</topic><topic>Pneumology/Respiratory System</topic><topic>Wound Infection - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asensio, M. J.</creatorcontrib><creatorcontrib>Sánchez, M.</creatorcontrib><creatorcontrib>Galván, B.</creatorcontrib><creatorcontrib>Herrero, E.</creatorcontrib><creatorcontrib>Cachafeiro, L.</creatorcontrib><creatorcontrib>Agrifoglio, A.</creatorcontrib><creatorcontrib>Perales, E.</creatorcontrib><creatorcontrib>Luque, S.</creatorcontrib><creatorcontrib>García-de-Lorenzo, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asensio, M. J.</au><au>Sánchez, M.</au><au>Galván, B.</au><au>Herrero, E.</au><au>Cachafeiro, L.</au><au>Agrifoglio, A.</au><au>Perales, E.</au><au>Luque, S.</au><au>García-de-Lorenzo, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries</atitle><jtitle>Intensive care medicine</jtitle><stitle>Intensive Care Med</stitle><addtitle>Intensive Care Med</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>41</volume><issue>2</issue><spage>371</spage><epage>372</epage><pages>371-372</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>25465909</pmid><doi>10.1007/s00134-014-3586-z</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0342-4642 |
| ispartof | Intensive care medicine, 2015-02, Vol.41 (2), p.371-372 |
| issn | 0342-4642 1432-1238 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1652460193 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Adolescent Adult Aged Anesthesiology Antifungal Agents - administration & dosage Antifungal Agents - blood Antifungal Agents - therapeutic use Burns Burns - complications Burns - drug therapy Burns and scalds Candidiasis, Invasive - drug therapy Caspofungin Critical Care Critical Care Medicine Critical Illness Drug dosages Echinocandins - administration & dosage Echinocandins - blood Echinocandins - therapeutic use Emergency Medicine Female Health aspects Humans Infections Intensive Intensive care Letter Lipopeptides - administration & dosage Lipopeptides - blood Lipopeptides - therapeutic use Male Medicine Medicine & Public Health Middle Aged Mortality Pain Medicine Patients Pediatrics Pharmacokinetics Plasma Plasma physics Pneumology/Respiratory System Wound Infection - drug therapy Young Adult |
| title | Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T00%3A51%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Micafungin%20at%20a%20standard%20dosage%20of%20100%C2%A0mg/day%20achieves%20adequate%20plasma%20exposure%20in%20critically%20ill%20patients%20with%20severe%20burn%20injuries&rft.jtitle=Intensive%20care%20medicine&rft.au=Asensio,%20M.%20J.&rft.date=2015-02-01&rft.volume=41&rft.issue=2&rft.spage=371&rft.epage=372&rft.pages=371-372&rft.issn=0342-4642&rft.eissn=1432-1238&rft_id=info:doi/10.1007/s00134-014-3586-z&rft_dat=%3Cgale_proqu%3EA724290916%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1650840767&rft_id=info:pmid/25465909&rft_galeid=A724290916&rfr_iscdi=true |